Global Molecular Diagnosis Of Rectal Cancer Market Research Report 2025(Status and Outlook)

October 2025 | 147 pages | ID: G522C5464FEFEN
Bosson Research

Abstracts

Report Overview

A molecular approach for diagnosing rectal cancer

The global Molecular Diagnosis Of Rectal Cancer market size was estimated at USD 485.2 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Molecular Diagnosis Of Rectal Cancer market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Molecular Diagnosis Of Rectal Cancer market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Molecular Diagnosis Of Rectal Cancer market

Global Molecular Diagnosis Of Rectal Cancer Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Kingmed
Geneis
Unitedgene
Yin Feng Gene
Inmedi
Amoydx
Genetronhealth
Berryoncology
Topgen
Roche
Qiagen

Market Segmentation (by Type)

PCR
FISH
DNA Sequencing
Gene Chip

Market Segmentation (by Application)

Clinical Diagnosis
Drug Screening
Research

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Molecular Diagnosis Of Rectal Cancer Market
• Overview of the regional outlook of the Molecular Diagnosis Of Rectal Cancer Market.

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Diagnosis Of Rectal Cancer Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Molecular Diagnosis Of Rectal Cancer, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Molecular Diagnosis Of Rectal Cancer
1.2 Key Market Segments
  1.2.1 Molecular Diagnosis Of Rectal Cancer Segment by Type
  1.2.2 Molecular Diagnosis Of Rectal Cancer Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MOLECULAR DIAGNOSIS OF RECTAL CANCER MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Molecular Diagnosis Of Rectal Cancer Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Molecular Diagnosis Of Rectal Cancer Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MOLECULAR DIAGNOSIS OF RECTAL CANCER MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Molecular Diagnosis Of Rectal Cancer Product Life Cycle
3.3 Global Molecular Diagnosis Of Rectal Cancer Sales by Manufacturers (2020-2025)
3.4 Global Molecular Diagnosis Of Rectal Cancer Revenue Market Share by Manufacturers (2020-2025)
3.5 Molecular Diagnosis Of Rectal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Molecular Diagnosis Of Rectal Cancer Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Molecular Diagnosis Of Rectal Cancer Market Competitive Situation and Trends
  3.8.1 Molecular Diagnosis Of Rectal Cancer Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Molecular Diagnosis Of Rectal Cancer Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MOLECULAR DIAGNOSIS OF RECTAL CANCER INDUSTRY CHAIN ANALYSIS

4.1 Molecular Diagnosis Of Rectal Cancer Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR DIAGNOSIS OF RECTAL CANCER MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Molecular Diagnosis Of Rectal Cancer Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Molecular Diagnosis Of Rectal Cancer Market
5.7 ESG Ratings of Leading Companies

6 MOLECULAR DIAGNOSIS OF RECTAL CANCER MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Diagnosis Of Rectal Cancer Sales Market Share by Type (2020-2025)
6.3 Global Molecular Diagnosis Of Rectal Cancer Market Size Market Share by Type (2020-2025)
6.4 Global Molecular Diagnosis Of Rectal Cancer Price by Type (2020-2025)

7 MOLECULAR DIAGNOSIS OF RECTAL CANCER MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Diagnosis Of Rectal Cancer Market Sales by Application (2020-2025)
7.3 Global Molecular Diagnosis Of Rectal Cancer Market Size (M USD) by Application (2020-2025)
7.4 Global Molecular Diagnosis Of Rectal Cancer Sales Growth Rate by Application (2020-2025)

8 MOLECULAR DIAGNOSIS OF RECTAL CANCER MARKET SALES BY REGION

8.1 Global Molecular Diagnosis Of Rectal Cancer Sales by Region
  8.1.1 Global Molecular Diagnosis Of Rectal Cancer Sales by Region
  8.1.2 Global Molecular Diagnosis Of Rectal Cancer Sales Market Share by Region
8.2 Global Molecular Diagnosis Of Rectal Cancer Market Size by Region
  8.2.1 Global Molecular Diagnosis Of Rectal Cancer Market Size by Region
  8.2.2 Global Molecular Diagnosis Of Rectal Cancer Market Size Market Share by Region
8.3 North America
  8.3.1 North America Molecular Diagnosis Of Rectal Cancer Sales by Country
  8.3.2 North America Molecular Diagnosis Of Rectal Cancer Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Molecular Diagnosis Of Rectal Cancer Sales by Country
  8.4.2 Europe Molecular Diagnosis Of Rectal Cancer Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Molecular Diagnosis Of Rectal Cancer Sales by Region
  8.5.2 Asia Pacific Molecular Diagnosis Of Rectal Cancer Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Molecular Diagnosis Of Rectal Cancer Sales by Country
  8.6.2 South America Molecular Diagnosis Of Rectal Cancer Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Molecular Diagnosis Of Rectal Cancer Sales by Region
  8.7.2 Middle East and Africa Molecular Diagnosis Of Rectal Cancer Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 MOLECULAR DIAGNOSIS OF RECTAL CANCER MARKET PRODUCTION BY REGION

9.1 Global Production of Molecular Diagnosis Of Rectal Cancer by Region(2020-2025)
9.2 Global Molecular Diagnosis Of Rectal Cancer Revenue Market Share by Region (2020-2025)
9.3 Global Molecular Diagnosis Of Rectal Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Molecular Diagnosis Of Rectal Cancer Production
  9.4.1 North America Molecular Diagnosis Of Rectal Cancer Production Growth Rate (2020-2025)
  9.4.2 North America Molecular Diagnosis Of Rectal Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Molecular Diagnosis Of Rectal Cancer Production
  9.5.1 Europe Molecular Diagnosis Of Rectal Cancer Production Growth Rate (2020-2025)
  9.5.2 Europe Molecular Diagnosis Of Rectal Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Molecular Diagnosis Of Rectal Cancer Production (2020-2025)
  9.6.1 Japan Molecular Diagnosis Of Rectal Cancer Production Growth Rate (2020-2025)
  9.6.2 Japan Molecular Diagnosis Of Rectal Cancer Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Molecular Diagnosis Of Rectal Cancer Production (2020-2025)
  9.7.1 China Molecular Diagnosis Of Rectal Cancer Production Growth Rate (2020-2025)
  9.7.2 China Molecular Diagnosis Of Rectal Cancer Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Kingmed
  10.1.1 Kingmed Basic Information
  10.1.2 Kingmed Molecular Diagnosis Of Rectal Cancer Product Overview
  10.1.3 Kingmed Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.1.4 Kingmed Business Overview
  10.1.5 Kingmed SWOT Analysis
  10.1.6 Kingmed Recent Developments
10.2 Geneis
  10.2.1 Geneis Basic Information
  10.2.2 Geneis Molecular Diagnosis Of Rectal Cancer Product Overview
  10.2.3 Geneis Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.2.4 Geneis Business Overview
  10.2.5 Geneis SWOT Analysis
  10.2.6 Geneis Recent Developments
10.3 Unitedgene
  10.3.1 Unitedgene Basic Information
  10.3.2 Unitedgene Molecular Diagnosis Of Rectal Cancer Product Overview
  10.3.3 Unitedgene Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.3.4 Unitedgene Business Overview
  10.3.5 Unitedgene SWOT Analysis
  10.3.6 Unitedgene Recent Developments
10.4 Yin Feng Gene
  10.4.1 Yin Feng Gene Basic Information
  10.4.2 Yin Feng Gene Molecular Diagnosis Of Rectal Cancer Product Overview
  10.4.3 Yin Feng Gene Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.4.4 Yin Feng Gene Business Overview
  10.4.5 Yin Feng Gene Recent Developments
10.5 Inmedi
  10.5.1 Inmedi Basic Information
  10.5.2 Inmedi Molecular Diagnosis Of Rectal Cancer Product Overview
  10.5.3 Inmedi Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.5.4 Inmedi Business Overview
  10.5.5 Inmedi Recent Developments
10.6 Amoydx
  10.6.1 Amoydx Basic Information
  10.6.2 Amoydx Molecular Diagnosis Of Rectal Cancer Product Overview
  10.6.3 Amoydx Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.6.4 Amoydx Business Overview
  10.6.5 Amoydx Recent Developments
10.7 Genetronhealth
  10.7.1 Genetronhealth Basic Information
  10.7.2 Genetronhealth Molecular Diagnosis Of Rectal Cancer Product Overview
  10.7.3 Genetronhealth Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.7.4 Genetronhealth Business Overview
  10.7.5 Genetronhealth Recent Developments
10.8 Berryoncology
  10.8.1 Berryoncology Basic Information
  10.8.2 Berryoncology Molecular Diagnosis Of Rectal Cancer Product Overview
  10.8.3 Berryoncology Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.8.4 Berryoncology Business Overview
  10.8.5 Berryoncology Recent Developments
10.9 Topgen
  10.9.1 Topgen Basic Information
  10.9.2 Topgen Molecular Diagnosis Of Rectal Cancer Product Overview
  10.9.3 Topgen Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.9.4 Topgen Business Overview
  10.9.5 Topgen Recent Developments
10.10 Roche
  10.10.1 Roche Basic Information
  10.10.2 Roche Molecular Diagnosis Of Rectal Cancer Product Overview
  10.10.3 Roche Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.10.4 Roche Business Overview
  10.10.5 Roche Recent Developments
10.11 Qiagen
  10.11.1 Qiagen Basic Information
  10.11.2 Qiagen Molecular Diagnosis Of Rectal Cancer Product Overview
  10.11.3 Qiagen Molecular Diagnosis Of Rectal Cancer Product Market Performance
  10.11.4 Qiagen Business Overview
  10.11.5 Qiagen Recent Developments

11 MOLECULAR DIAGNOSIS OF RECTAL CANCER MARKET FORECAST BY REGION

11.1 Global Molecular Diagnosis Of Rectal Cancer Market Size Forecast
11.2 Global Molecular Diagnosis Of Rectal Cancer Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Country
  11.2.3 Asia Pacific Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Region
  11.2.4 South America Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Molecular Diagnosis Of Rectal Cancer by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Molecular Diagnosis Of Rectal Cancer Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Molecular Diagnosis Of Rectal Cancer by Type (2026-2033)
  12.1.2 Global Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Molecular Diagnosis Of Rectal Cancer by Type (2026-2033)
12.2 Global Molecular Diagnosis Of Rectal Cancer Market Forecast by Application (2026-2033)
  12.2.1 Global Molecular Diagnosis Of Rectal Cancer Sales (K Units) Forecast by Application
  12.2.2 Global Molecular Diagnosis Of Rectal Cancer Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Molecular Diagnosis Of Rectal Cancer Market Size Comparison by Region (M USD)
Table 5. Global Molecular Diagnosis Of Rectal Cancer Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Molecular Diagnosis Of Rectal Cancer Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Molecular Diagnosis Of Rectal Cancer Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Molecular Diagnosis Of Rectal Cancer Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis Of Rectal Cancer as of 2024)
Table 10. Global Market Molecular Diagnosis Of Rectal Cancer Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Molecular Diagnosis Of Rectal Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Molecular Diagnosis Of Rectal Cancer Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Molecular Diagnosis Of Rectal Cancer Sales by Type (K Units)
Table 26. Global Molecular Diagnosis Of Rectal Cancer Market Size by Type (M USD)
Table 27. Global Molecular Diagnosis Of Rectal Cancer Sales (K Units) by Type (2020-2025)
Table 28. Global Molecular Diagnosis Of Rectal Cancer Sales Market Share by Type (2020-2025)
Table 29. Global Molecular Diagnosis Of Rectal Cancer Market Size (M USD) by Type (2020-2025)
Table 30. Global Molecular Diagnosis Of Rectal Cancer Market Size Share by Type (2020-2025)
Table 31. Global Molecular Diagnosis Of Rectal Cancer Price (USD/Unit) by Type (2020-2025)
Table 32. Global Molecular Diagnosis Of Rectal Cancer Sales (K Units) by Application
Table 33. Global Molecular Diagnosis Of Rectal Cancer Market Size by Application
Table 34. Global Molecular Diagnosis Of Rectal Cancer Sales by Application (2020-2025) & (K Units)
Table 35. Global Molecular Diagnosis Of Rectal Cancer Sales Market Share by Application (2020-2025)
Table 36. Global Molecular Diagnosis Of Rectal Cancer Market Size by Application (2020-2025) & (M USD)
Table 37. Global Molecular Diagnosis Of Rectal Cancer Market Share by Application (2020-2025)
Table 38. Global Molecular Diagnosis Of Rectal Cancer Sales Growth Rate by Application (2020-2025)
Table 39. Global Molecular Diagnosis Of Rectal Cancer Sales by Region (2020-2025) & (K Units)
Table 40. Global Molecular Diagnosis Of Rectal Cancer Sales Market Share by Region (2020-2025)
Table 41. Global Molecular Diagnosis Of Rectal Cancer Market Size by Region (2020-2025) & (M USD)
Table 42. Global Molecular Diagnosis Of Rectal Cancer Market Size Market Share by Region (2020-2025)
Table 43. North America Molecular Diagnosis Of Rectal Cancer Sales by Country (2020-2025) & (K Units)
Table 44. North America Molecular Diagnosis Of Rectal Cancer Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Molecular Diagnosis Of Rectal Cancer Sales by Country (2020-2025) & (K Units)
Table 46. Europe Molecular Diagnosis Of Rectal Cancer Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Molecular Diagnosis Of Rectal Cancer Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Molecular Diagnosis Of Rectal Cancer Market Size by Region (2020-2025) & (M USD)
Table 49. South America Molecular Diagnosis Of Rectal Cancer Sales by Country (2020-2025) & (K Units)
Table 50. South America Molecular Diagnosis Of Rectal Cancer Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Molecular Diagnosis Of Rectal Cancer Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Molecular Diagnosis Of Rectal Cancer Market Size by Region (2020-2025) & (M USD)
Table 53. Global Molecular Diagnosis Of Rectal Cancer Production (K Units) by Region(2020-2025)
Table 54. Global Molecular Diagnosis Of Rectal Cancer Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Molecular Diagnosis Of Rectal Cancer Revenue Market Share by Region (2020-2025)
Table 56. Global Molecular Diagnosis Of Rectal Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Molecular Diagnosis Of Rectal Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Molecular Diagnosis Of Rectal Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Molecular Diagnosis Of Rectal Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Molecular Diagnosis Of Rectal Cancer Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Kingmed Basic Information
Table 62. Kingmed Molecular Diagnosis Of Rectal Cancer Product Overview
Table 63. Kingmed Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Kingmed Business Overview
Table 65. Kingmed SWOT Analysis
Table 66. Kingmed Recent Developments
Table 67. Geneis Basic Information
Table 68. Geneis Molecular Diagnosis Of Rectal Cancer Product Overview
Table 69. Geneis Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Geneis Business Overview
Table 71. Geneis SWOT Analysis
Table 72. Geneis Recent Developments
Table 73. Unitedgene Basic Information
Table 74. Unitedgene Molecular Diagnosis Of Rectal Cancer Product Overview
Table 75. Unitedgene Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Unitedgene Business Overview
Table 77. Unitedgene SWOT Analysis
Table 78. Unitedgene Recent Developments
Table 79. Yin Feng Gene Basic Information
Table 80. Yin Feng Gene Molecular Diagnosis Of Rectal Cancer Product Overview
Table 81. Yin Feng Gene Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Yin Feng Gene Business Overview
Table 83. Yin Feng Gene Recent Developments
Table 84. Inmedi Basic Information
Table 85. Inmedi Molecular Diagnosis Of Rectal Cancer Product Overview
Table 86. Inmedi Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Inmedi Business Overview
Table 88. Inmedi Recent Developments
Table 89. Amoydx Basic Information
Table 90. Amoydx Molecular Diagnosis Of Rectal Cancer Product Overview
Table 91. Amoydx Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Amoydx Business Overview
Table 93. Amoydx Recent Developments
Table 94. Genetronhealth Basic Information
Table 95. Genetronhealth Molecular Diagnosis Of Rectal Cancer Product Overview
Table 96. Genetronhealth Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Genetronhealth Business Overview
Table 98. Genetronhealth Recent Developments
Table 99. Berryoncology Basic Information
Table 100. Berryoncology Molecular Diagnosis Of Rectal Cancer Product Overview
Table 101. Berryoncology Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Berryoncology Business Overview
Table 103. Berryoncology Recent Developments
Table 104. Topgen Basic Information
Table 105. Topgen Molecular Diagnosis Of Rectal Cancer Product Overview
Table 106. Topgen Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Topgen Business Overview
Table 108. Topgen Recent Developments
Table 109. Roche Basic Information
Table 110. Roche Molecular Diagnosis Of Rectal Cancer Product Overview
Table 111. Roche Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Roche Business Overview
Table 113. Roche Recent Developments
Table 114. Qiagen Basic Information
Table 115. Qiagen Molecular Diagnosis Of Rectal Cancer Product Overview
Table 116. Qiagen Molecular Diagnosis Of Rectal Cancer Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Qiagen Business Overview
Table 118. Qiagen Recent Developments
Table 119. Global Molecular Diagnosis Of Rectal Cancer Sales Forecast by Region (2026-2033) & (K Units)
Table 120. Global Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Region (2026-2033) & (M USD)
Table 121. North America Molecular Diagnosis Of Rectal Cancer Sales Forecast by Country (2026-2033) & (K Units)
Table 122. North America Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 123. Europe Molecular Diagnosis Of Rectal Cancer Sales Forecast by Country (2026-2033) & (K Units)
Table 124. Europe Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 125. Asia Pacific Molecular Diagnosis Of Rectal Cancer Sales Forecast by Region (2026-2033) & (K Units)
Table 126. Asia Pacific Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Region (2026-2033) & (M USD)
Table 127. South America Molecular Diagnosis Of Rectal Cancer Sales Forecast by Country (2026-2033) & (K Units)
Table 128. South America Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Middle East and Africa Molecular Diagnosis Of Rectal Cancer Sales Forecast by Country (2026-2033) & (Units)
Table 130. Middle East and Africa Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Country (2026-2033) & (M USD)
Table 131. Global Molecular Diagnosis Of Rectal Cancer Sales Forecast by Type (2026-2033) & (K Units)
Table 132. Global Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Type (2026-2033) & (M USD)
Table 133. Global Molecular Diagnosis Of Rectal Cancer Price Forecast by Type (2026-2033) & (USD/Unit)
Table 134. Global Molecular Diagnosis Of Rectal Cancer Sales (K Units) Forecast by Application (2026-2033)
Table 135. Global Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Molecular Diagnosis Of Rectal Cancer
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Diagnosis Of Rectal Cancer Market Size (M USD), 2024-2033
Figure 5. Global Molecular Diagnosis Of Rectal Cancer Market Size (M USD) (2020-2033)
Figure 6. Global Molecular Diagnosis Of Rectal Cancer Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Diagnosis Of Rectal Cancer Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Molecular Diagnosis Of Rectal Cancer Product Life Cycle
Figure 13. Molecular Diagnosis Of Rectal Cancer Sales Share by Manufacturers in 2024
Figure 14. Global Molecular Diagnosis Of Rectal Cancer Revenue Share by Manufacturers in 2024
Figure 15. Molecular Diagnosis Of Rectal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Molecular Diagnosis Of Rectal Cancer Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Molecular Diagnosis Of Rectal Cancer Revenue in 2024
Figure 18. Industry Chain Map of Molecular Diagnosis Of Rectal Cancer
Figure 19. Global Molecular Diagnosis Of Rectal Cancer Market PEST Analysis
Figure 20. Global Molecular Diagnosis Of Rectal Cancer Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Molecular Diagnosis Of Rectal Cancer Market Share by Type
Figure 27. Sales Market Share of Molecular Diagnosis Of Rectal Cancer by Type (2020-2025)
Figure 28. Sales Market Share of Molecular Diagnosis Of Rectal Cancer by Type in 2024
Figure 29. Market Size Share of Molecular Diagnosis Of Rectal Cancer by Type (2020-2025)
Figure 30. Market Size Share of Molecular Diagnosis Of Rectal Cancer by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Molecular Diagnosis Of Rectal Cancer Market Share by Application
Figure 33. Global Molecular Diagnosis Of Rectal Cancer Sales Market Share by Application (2020-2025)
Figure 34. Global Molecular Diagnosis Of Rectal Cancer Sales Market Share by Application in 2024
Figure 35. Global Molecular Diagnosis Of Rectal Cancer Market Share by Application (2020-2025)
Figure 36. Global Molecular Diagnosis Of Rectal Cancer Market Share by Application in 2024
Figure 37. Global Molecular Diagnosis Of Rectal Cancer Sales Growth Rate by Application (2020-2025)
Figure 38. Global Molecular Diagnosis Of Rectal Cancer Sales Market Share by Region (2020-2025)
Figure 39. Global Molecular Diagnosis Of Rectal Cancer Market Size Market Share by Region (2020-2025)
Figure 40. North America Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Molecular Diagnosis Of Rectal Cancer Sales Market Share by Country in 2024
Figure 43. North America Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Molecular Diagnosis Of Rectal Cancer Market Size Market Share by Country in 2024
Figure 45. U.S. Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Molecular Diagnosis Of Rectal Cancer Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Molecular Diagnosis Of Rectal Cancer Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Molecular Diagnosis Of Rectal Cancer Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Molecular Diagnosis Of Rectal Cancer Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Molecular Diagnosis Of Rectal Cancer Sales Market Share by Country in 2024
Figure 53. Europe Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Molecular Diagnosis Of Rectal Cancer Market Size Market Share by Country in 2024
Figure 55. Germany Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Molecular Diagnosis Of Rectal Cancer Sales Market Share by Region in 2024
Figure 67. Asia Pacific Molecular Diagnosis Of Rectal Cancer Market Size Market Share by Region in 2024
Figure 68. China Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (K Units)
Figure 79. South America Molecular Diagnosis Of Rectal Cancer Sales Market Share by Country in 2024
Figure 80. South America Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (M USD)
Figure 81. South America Molecular Diagnosis Of Rectal Cancer Market Size Market Share by Country in 2024
Figure 82. Brazil Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Molecular Diagnosis Of Rectal Cancer Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Molecular Diagnosis Of Rectal Cancer Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Molecular Diagnosis Of Rectal Cancer Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Molecular Diagnosis Of Rectal Cancer Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Molecular Diagnosis Of Rectal Cancer Production Market Share by Region (2020-2025)
Figure 103. North America Molecular Diagnosis Of Rectal Cancer Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Molecular Diagnosis Of Rectal Cancer Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Molecular Diagnosis Of Rectal Cancer Production (K Units) Growth Rate (2020-2025)
Figure 106. China Molecular Diagnosis Of Rectal Cancer Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Molecular Diagnosis Of Rectal Cancer Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Molecular Diagnosis Of Rectal Cancer Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Molecular Diagnosis Of Rectal Cancer Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Molecular Diagnosis Of Rectal Cancer Market Share Forecast by Type (2026-2033)
Figure 111. Global Molecular Diagnosis Of Rectal Cancer Sales Forecast by Application (2026-2033)
Figure 112. Global Molecular Diagnosis Of Rectal Cancer Market Share Forecast by Application (2026-2033)